References
  1. Morais-Almeida M, Barbosa M, Sousa CS, Aguiar R, Bousquet J, Update on asthma prevalence in severe COVID-19 patients, Allergy. press
  2. Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018 Feb 24;391(10122):783-800. doi: 10.1016/S0140-6736(17)33311-1
  3. Wendan S, Ziang G, Yongjun D, Ting Z, Wei Z, Yu X, Clinical characteristics of COVID-19 patients combined with allergy, Allergy. 2020. Doi: 10.1111/ALL.14434
  4. Camiolo MJ, Gauthier M, Kaminski N, Ray A, Wenzel SE. Expression of SARS-CoV-2 Receptor ACE2 and Coincident Host Response Signature Varies by Asthma Inflammatory Phenotype [published online ahead of print, 2020 Jun 9]. J Allergy Clin Immunol . 2020; S0091-6749(20)30828-9. doi:10.1016/j.jaci.2020.05.051
  5. Avdeev S, Moiseev S, et al. Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19, Allergy. 2020. Doi: 10.1111/ALL.14420
  6. Garg S, Kim L, Whitaker M, et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep 2020;69:458–464. DOI: 10.15585/mmwr.mm6915e3
  7. Gémes, K., Talbäck, M., Modig, K. et al. Burden and prevalence of prognostic factors for severe COVID- Sweden. Eur J Epidemiol35, 401–409 (2020).https://doi.org/10.1007/s10654-020-00646-z
  8. Williamson E, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE; The OpenSAFELY Collaborative. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. 2020 May 7. medRxiv preprint doi:https://doi.org/10.1101/2020.05.06.20092999